NEW YORK (GenomeWeb) – Plexera Biotechnology and JPT Peptide Technologies today announced a deal to distribute JPT's peptide-based products and services in China and to develop peptide-based applications on Plexera's PlexArray HT platform for high-throughput proteomics screening. 

Plexera will distribute JPT's products and services to the Chinese proteomics, immunotherapy, and vaccine markets, the companies said. Financial and other terms of the agreement were not disclosed. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.